Abstract
The classical concept of assuming that an i.v. dose instantaneously distributes into the central or plasma compartment is reviewed, as is the potential for pulmonary first-pass effect. Based on available literature, the concept is shown to lead to serious errors in estimating pharmacokinetic parameters, particularly for drugs with high clearance.
Similar content being viewed by others
References
J. C. K. Loo and S. Riegelman. Assessment of pharmacokinetic constants from postinfusion blood curves obtained after IV infusion.J. Pharm. Sci. 58:53–55 (1969).
W. L. Chiou. A simple equation to estimate the percent of drug remaining in the body after an intraveneous injection.J. Pharm. Pharmacol. 24:342–344 (1972).
J. G. Wagner. Linear pharmacokinetic equations allowing direct calculation of many needed pharmacokinetic parameters from the coefficients and exponents of polyexponential equations which have been fitted to the data.J. Pharmacokin. Biopharm. 4:443–467 (1976).
M. Gibaldi and D. Perrier.Pharmacokinetics, Dekker, New York, 1975.
E. G. McQueen and W. M. Wardell. Drug displacement from protein binding: Isolation of redistributional drug interactionin vivo.Br. J. Pharmacol. 43:312–324 (1971).
J. C. Broadbent and E. H. Wood. Indicator-dilution curves in acyanotic congenital heart disease.Circulation 9:890–901 (1954).
J. D. Boyett, D. E. Stowe, L. H. Becker, and W. E. Britz. Rapid method for determination of cardiac output by indicator techniques.J. Lab. Clin. Med. 64:160–167 (1964).
A. C. Guyton,Textbook of Medical Physiology, 4th ed., Saunders, Philadelphia, 1971, pp. 322–333.
D. S. Riggs,The Mathematical Approach to Physiological Problems, MIT Press, Cambridge, Mass., 1963, pp. 225–228.
J. W. Nicholson and E. H. Wood. Estimation of cardiac output and Evans blue space in man, using an oximeter.J. Lab. Clin. Med. 38:588–603 (1951).
J. Fox and E. H. Wood. Blood flow measurements by dye dilutechniques. In O. Glaser, (ed.),Medical Physics, Vol. III, Year Book Publishers, Chicago, 1969.
N. Benowitz, R. P. Forsyth, K. L. Melmon, and M. Rowland. Lidocaine disposition kinetics in monkey and man. I. Prediction by a perfusion model.Clin. Pharmacol. Ther. 16:87–98 (1974).
C. R. Kowarski and A. A. Kowarski. Constant blood withdrawal method for area under plasma concentration-time curve.J. Pharm. Sci. 67:875–876 (1978).
S. M. Shnider and E. L. Way. The kinetics of transfer of lidocaine (xylocaine) across the human placenta.Anesthesiology 29:944–950 (1968).
S. A. Kaplan, M. L. Jack, K. Alexander, and R. E. Weinfeld. Pharmacokinetic profile of diazepam in man following single intravenous and oral and chronic oral administrations.J. Pharm. Sci. 62:1789–1796 (1973).
K. L. Lynn, T. J. Neale, P. J. Little, and R. R. Bailey. Gentamicin by intravenous bolus injection.N.Z. Med. J. 80:442–443 (1974).
P. H. Hinderung and E. R. Garrett. Pharmacokinetics of the antiarrhythmic disopyramide in healthy humans.J. Pharmacokin. Biopharm. 4:199–230 (1976).
A. MacDonald, A. F. Michaelis, and B. Z. Senkowski. Diazepam. In K. Florey (ed.),Analytical Profiles of Drug Substances, Vol. 1, Academic Press, New York, 1972.
K. Chang and W. L. Chiou. Release and dynamic supersaturation profiles of drugs from molecularly dispersed solutions. I. Liquid solutions of medroxyprogesterone acetate and digitoxin. Presented (abstract) to the APhA Academy of Pharmaceutical Sciences Meeting, Orlando, Fla., 1976.
B.-Y. Cheng. Studies on the supersaturation of drugs from solution systems. A thesis submitted to the Graduate College, University of Illinois Medical Center in partial fulfillment of M.S. degree in Sciences, 1977.
S. H. Curry,Drug Disposition and Pharmacokinetics with a Consideration of Pharmacological and Clinical Relationship, 2nd ed., Blackwell Scientific Publications, Oxford, 1977, pp. 92, 148.
J. G. Gibson and W. A. Evans. Clinical studies of the blood volume. I. Clinical application of a method employing the azo dye “Evans blue” and the spectrophotometer.J. Clin. Invest. 16:301–316 (1937).
A. Goldstein, L. Aronow, and S. M. Kalman.Principles of Drug Action: The Basis of Pharmacology, 2nd ed., Wiley, New York, 1974.
N. K. Athanikar and W. L. Chiou. Chloropheniramine. II. Effect of the first-pass metabolism on the oral bioavailability in dogs.J. Pharmacokin. Biopharm. 7:383–396 (1979).
S. M. Wallace and S. Riegelman. Uptake of acetazolamide by human erythrocytesin vitro.J. Pharm. Sci. 66:729–731 (1977).
A. N. Chremos, D. Shen, M. Fibaldi, J. D. Proctor, and J. H. Newman. Time-dependent change in renal clearance of bethanidine in humans.J. Pharm. Sci. 65:140–142 (1976).
W. L. Chiou. Dose- and dosage-form dependent pharmacokinetics of phenacetin and its metabolite in man.J. Clin. Pharmacol. 14:418–425 (1974).
W. L. Chiou. Quantitation of hepatic and pulmonary first-pass effects and its implications in pharmacokinetic study I. Pharmacokinetics of chloroform in man.J. Pharmacokin. Biopharm. 3:193–201 (1975).
W. L. Chiou. Estimation of hepatic first-pass effect of acetaminophen in man after oral administration.J. Pharm. Sci. 64:1734–1735 (1975).
W. L. Chiou. Equations to estimate the extent of first-pass effect and the apparent volume of distribution of drug with incomplete oral absorption and partial elimination through renal excretion.J. Pharm. Sci. 68:260 (1979).
S. H. Ferreirea and J. R. Vane. Prostaglandins: Their disappearance from and release into the circulation.Nature 216:868–873 (1967).
E. A. B. Brown. The localization, metabolism, and effects of drugs and toxicants in lung.Drug Metab. Rev. 3:33–87 (1974).
P. Jose, U. Niederhauser, P. J. Piper, C. Robinson, and A. P. Smith. Degradation of prostaglandin F2α in the human pulmonary circulation.Thorax 31:713–719 (1976).
G. L. Hammond, L. H. Cronau, D. Whittaker, and C. N. Gillis. Fate of prostaglandins E1 and A1 in the human pulmonary circulation.Surgery 81:716–722 (1977).
R. M. Welch, J. Cavalito, and A. Loh. Effect of exposure to cigarette smoke on the metabolism of benxo(a)pyrene and acetophenetidin by lung and intestine of rats.Toxicol. Appl. Pharmacol. 1:749–758 (1972).
S. Niazi and W. L. Chiou. Fluorocarbon aerosol propellant. IV. Pharmacokinetics of trichloromonofluoromethane following single and multiple dosing in dogs.J. Pharm. Sci. 64:763–769 (1975).
S. Niazi and W. L. Chiou. Fluorocarbon aerosol propellants. X: Pharmacokinetics of dichlorotetrafluoroethane in dogs.J. Pharm. Sci. 65:60–64 (1976).
S. Niazi and W. L. Chiou. Fluorocarbon aerosol propellants. XI. Pharmacokinetics of dichlorodifluoroethane in dogs following single and multiple dosing.J. Pharm. Sci. 66:49–53 (1977).
W. L. Chiou. Apparent volume of distribution, pulmonary clearance and bioavailability of volatile or gaseous compounds after peripheral intraveneous dosing.Res. Commun. Chem. Pathol. Pharmacol. 7:679–688 (1974).
W. L. Chiou and F. H. Hsu. Pharmacokinetics of creatinine in man and its implications in the monitoring of renal function and in dosage regimen modifications in patients with renal insufficiency.J. Clin. Pharmacol. 15:427–434 (1975).
W. L. Chiou and F. H. Hsu. A new simple and rapid method to monitor the renal function based on pharmacokinetic consideration of endogenous creatinine.Res. Commun. Chem. Pathol. Pharmacol. 10:315–330 (1975).
W. L. Chiou, G. W. Peng, and R. L. Nation. Rapid estimation of volume of distribution after a short intravenous infusion and its application to dosing adjustments.J. Clin. Pharmacol. 18:266–271 (1978).
W. L. Chiou, M. A. F. Galdalla, and G. W. Peng. Method for the rapid estimation of the total body drug clearance and adjustment of dosage regimens in patients during a constant-rate intravenous infusion.J. Pharmacokin. Biopharm. 6:135–151 (1978).
W. L. Chiou, S. M. Huang, and Y. C. Huang. Midpoint back-extrapolation method for the rapid estimation of volume of distribution and dosage adjustments of drugs exhibiting multicompartmental characteristics.Int. J. Clin. Pharmacol. Biopharm. (in press).
M. Gibaldi and G. Levy. Pharmacokinetics in clinical practice.J. Am. Med. Assoc. 235:1987–1992 (1976).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Chiou, W.L. Potential pitfalls in the conventional pharmacokinetic studies: Effects of the initial mixing of drug in blood and the pulmonary first-pass elimination. Journal of Pharmacokinetics and Biopharmaceutics 7, 527–536 (1979). https://doi.org/10.1007/BF01062393
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01062393